Is Colloidal Silver Safe?
- Colloidal silver can cause serious side effects. The most common is argyria, a bluish-gray discoloration of the skin, which is usually permanent.
- Colloidal silver can also cause poor absorption of some drugs, such as certain antibiotics and thyroxine (used to treat thyroid deficiency).
- The FDA also warned in 1999 that colloidal silver isn’t safe or effective for treating any disease or condition.
- The FDA and the Federal Trade Commission have taken action against a number of companies for making misleading claims about colloidal silver products.
More About Argyria
- Silver can build up in the body’s tissue, causing a bluish-gray discoloration of large areas of skin, especially those exposed to the sun.
- People have developed argyria from using homemade and commercial colloidal silver products.
Is Colloidal Silver Effective?
Scientific evidence doesn’t support the use of colloidal silver dietary supplements for any disease or condition.
- Silver has no known function or benefits in the body when taken by mouth.
- Silver is not a nutritionally essential mineral or a useful dietary supplement.
- People may be exposed to silver, usually in tiny amounts, through air, water, and food, and in certain activities such as jewelry-making or soldering.
- Colloidal silver products are sometimes sold as homeopathic remedies. For more information on homeopathy, see nccih.nih.gov/health/homeopathy.
- Topical silver (used on the skin) has some appropriate medical uses, such as in bandages and dressings to treat burns, skin wounds, or skin infections. It’s also in medicines to prevent conjunctivitis (an eye condition) in newborns. However, there are no legally marketed prescription or over-the-counter drugs containing colloidal silver that are taken by mouth.
More to Consider
- Colloidal silver and other complementary products or practices that have not been proven safe and effective should never be used to replace conventional medical care or as a reason to postpone seeing a health care provider about a medical problem.
- Tell all your health care providers about any complementary health approaches you use. Give them a full picture of what you do to manage your health. This will help ensure coordinated and safe care.
For More Information
The NCCIH Clearinghouse provides information on NCCIH and complementary and integrative health approaches, including publications and searches of Federal databases of scientific and medical literature. The Clearinghouse does not provide medical advice, treatment recommendations, or referrals to practitioners.
Toll-free in the U.S.: 1-888-644-6226
tty (for deaf and hard-of-hearing callers):
Email: firstname.lastname@example.org (link sends e-mail)
A service of the National Library of Medicine, PubMed® contains publication information and (in most cases) brief summaries of articles from scientific and medical journals. For guidance from NCCIH on using PubMed, see How To Find Information About Complementary Health Approaches on PubMed.
Safety Reporting Portal
The Safety Reporting Portal allows consumers, manufacturers, health care professionals, researchers, and public health officials to file reports on serious problems suspected with dietary supplements to the U.S. Food and Drug Administration and the National Institutes of Health.
Report adverse events at www.safetyreporting.hhs.gov.
Federal Trade Commission (FTC)
The FTC is the Federal agency charged with protecting the public against unfair and deceptive business practices. A key area of its work is the regulation of advertising (except for prescription drugs and medical devices).
Toll-free in the U.S.: 1-877-382-4357
- Agency for Toxic Substances and Disease Registry. ToxFAQs for Silver. Agency for Toxic Substances and Disease Registry Web site. Accessed at www.atsdr.cdc.gov/toxfaqs/tf.asp?id=538&tid=97 on January 18, 2012.
- Chung IS, Lee MY, Shin DH, et al. Three systemic argyria cases after ingestion of colloidal silver solution. International Journal of Dermatology. 2010;49(10):1175–1177.
- Han TY, Chang HS, Lee HK, et al. Successful treatment of argyria using a low-fluence Q-switched 1064-nm Nd:YAG laser. International Journal of Dermatology. 2011;50(6):751–753.
- U.S. Food and Drug Administration. Rules and regulations: over-the-counter drug products containing colloidal silver ingredients or silver salts. Final rule. Federal Register. 1999;64(158):44653–44658.
NCCIH thanks John (Jack) Killen, Jr., M.D., NCCIH, for his technical expertise and review of the content update of this publication.
This publication is not copyrighted and is in the public domain. Duplication is encouraged.
NCCIH has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by NCCIH.